Gergõ A Molnár, Zoltán Wagner, Lajos Markó, Tamás Kó Szegi, Márton Mohás, Béla Kocsis, Zoltán Matus, László Wagner, Mónika Tamaskó, István Mazák, Boglárka Laczy, Judit Nagy, István Wittmann
Index: Kidney Int. 68(5) , 2281-7, (2005)
Full Text: HTML
Phenylalanine is converted to para- and ortho-tyrosine by hydroxyl free radical, or to para-tyrosine by the phenylalanine hydroxylase enzyme. The aim of this study was to measure para- and ortho-tyrosine in the urine and plasma of patients with chronic renal disease and/or diabetes, to obtain information on the renal handling of the different tyrosine isomers and, furthermore, to measure urinary levels of 8-epi-prostaglandin-F(2alpha), a marker of lipid peroxidation.In our cross-sectional study we measured para-, ortho-tyrosine, and phenylalanine levels, using high performance liquid chromatography and 8-epi-prostaglandin-F(2alpha) with enzyme-linked immunosorbent assay (ELISA). We compared 4 groups: (1) controls (CONTR, N = 14), (2) patients with chronic kidney disease (CKD, N = 12), (3) patients with type 2 diabetes mellitus (DIAB, N = 17), (4) patients with chronic kidney disease and type 2 diabetes (DIAB-CKD, N = 19).We found a decreased plasma para-tyrosine level and decreased urinary para-tyrosine excretion in CKD patients, while the fractional excretion of para-tyrosine was similar in all 4 groups, approximately 1%. There was no difference in the plasma ortho-tyrosine levels between the groups. However, urinary ortho-tyrosine excretion was higher in all 3 groups of patients than in the CONTR group, and higher in DIAB and in DIAB-CKD patients than in CKD patients. The fractional excretion of ortho-tyrosine was significantly higher in DIAB and in DIAB-CKD patients than in the CONTR group. The fractional excretion of ortho-tyrosine exceeded 100% in the 2 diabetic groups. Urinary 8-epi-prostaglandin-F(2alpha)/creatinine ratio did not correlate with urinary ortho-tyrosine excretion.The difference between para-tyrosine levels of the groups is probably due to renal impairment, while there is indirect evidence for an increased tubular secretion or production of ortho-tyrosine in the kidney in diabetic patients with or without CKD.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
DL-O-Tyrosine
CAS:2370-61-8 |
C9H11NO3 |
Ion-pairing reversed-phase liquid chromatography fractionati...
2011-01-01 [J. Chromatogr. A. 1218(23) , 3689-94, (2011)] |
Concomitant tumor resistance: the role of tyrosine isomers i...
2012-03-01 [Cancer Res. 72(5) , 1043-50, (2012)] |
Mass spectrometric quantification of 3-nitrotyrosine, ortho-...
1999-12-03 [J. Biol. Chem. 274(49) , 34621-8, (1999)] |
Markers of protein oxidation by hydroxyl radical and reactiv...
1998-02-01 [Am. J. Physiol. 274(2 Pt 2) , R453-61, (1998)] |
Inhibitory effect of a two day fast on reactive oxygen speci...
2001-06-01 [J. Clin. Endocrinol. Metab. 86(6) , 2899-902, (2001)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved